American Thoracic Society 2024 International Conference
Find key updates on lung cancer prevention, screening, and treatment from the American Thoracic Society 2024 International Conference.
Research presented at ATS 2024 showed how patients with multimorbidity and limited life expectancy perceive screening.
Research presented at ATS 2024 addressed questions surrounding the use of this regimen in older adults.
Further efforts to improve electronic health record documentation of smoking history are “essential” to mitigate ...
The study addressed the limited information on the trajectory of patient-centered outcomes in this setting.
Research presented at ATS 2024 highlights the “potential harmful effects of alternative e-cigarette use.”
It was critical to offer the screening program because most veterans with lung cancer are diagnosed at stage III or IV.
A study presented at ATS 2024 shed light on the outcomes of patients with cannabis use disorder and lung cancer.
The findings offer insight into tumorigenesis in cigarette smoke exposure conditions.
Advertisement
Advertisement
